Cite Filings / LIMN
Feed Companies Filings Check
Sign in

CIK 0001971387

  • Emerging growth company

Liminatus Pharma, Inc.

Sign in to watch
Ticker
LIMN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 213-273-5453
Business address
12611 HIDDENCREEK WAY, UNIT C, CERRITOS, CA, 90703
Former names
Iris Parent Holding Corp.

Securities

  • LIMN Class A Common Stock Nasdaq
  • LIMNW Warrants Nasdaq
Filings Financials Insiders Search text
All 111 Financials 32 Shareholder Meetings 2 Executive Compensation 28 Insider Trading 16 Beneficial Ownership Interest 11 Business Combinations 32 Public Offerings 31 Mutual Funds and ETFs 1 Others 14
›
Filed in
  1. No filings match these filters. Clear filters
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-07-22
  3. SCHEDULE 13D/A Stake Beneficial Ownership Report 2026-07-14
  4. DEF 14A Proxy Proxy Statement 2026-07-13
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership 2026-07-06
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-02-20
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership 2025-06-27
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership 2025-06-26
  9. SCHEDULE 13G Stake Statement of Beneficial Ownership 2025-06-26
  10. SCHEDULE 13G Stake Statement of Beneficial Ownership 2025-06-26
  11. SCHEDULE 13D Stake ● Beneficial Ownership Report 2025-05-08
  12. SCHEDULE 13D Stake ● Beneficial Ownership Report 2025-05-07

Page 1 of 1 · 11 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…